Growth

A stock hit by temporary disruptions and one that is growing faster than it can manage.

Eley Griffiths' Nick Guidera tells the story of how he let caution override conviction and watched a stock rally from the sidelines.

How Aoris look through macro noise and focus on company culture to guide their current 14-stock portfolio selection.

The Continuous Glucose Monitor market is poised for structural growth, and we believe Dexcom is best positioned to dominate the growth cycle

Vinva analyses 15,000+ stocks and 3 million articles a year. Now, its data-driven edge is available to retail investors

Phil King reveals the strategies that help Regal get ahead, as Ophir and Macquarie stock pickers reveal their top methods to make money.

Paul Taylor has defied the odds for 22 years. Hear how he picks stocks, handles losses, and tunes out short-term market noise.